108 related articles for article (PubMed ID: 20573806)
21. Tetrahydroxystilbene glucoside ameliorates diabetic nephropathy in rats: involvement of SIRT1 and TGF-β1 pathway.
Li C; Cai F; Yang Y; Zhao X; Wang C; Li J; Jia Y; Tang J; Liu Q
Eur J Pharmacol; 2010 Dec; 649(1-3):382-9. PubMed ID: 20854812
[TBL] [Abstract][Full Text] [Related]
22. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
Susztak K; Raff AC; Schiffer M; Böttinger EP
Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
[TBL] [Abstract][Full Text] [Related]
23. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
Nam SM; Lee MY; Koh JH; Park JH; Shin JY; Shin YG; Koh SB; Lee EY; Chung CH
Diabetes Res Clin Pract; 2009 Feb; 83(2):176-82. PubMed ID: 19111363
[TBL] [Abstract][Full Text] [Related]
24. Diabetic nephropathy: introduction.
Breyer MD
Semin Nephrol; 2007 Mar; 27(2):129. PubMed ID: 17418681
[No Abstract] [Full Text] [Related]
25. Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy.
Wang JJ; Zhang SX; Mott R; Chen Y; Knapp RR; Cao W; Ma JX
Am J Physiol Renal Physiol; 2008 May; 294(5):F1166-73. PubMed ID: 18322021
[TBL] [Abstract][Full Text] [Related]
26. Thioredoxin interacting protein (TXNIP) regulates tubular autophagy and mitophagy in diabetic nephropathy through the mTOR signaling pathway.
Huang C; Zhang Y; Kelly DJ; Tan CY; Gill A; Cheng D; Braet F; Park JS; Sue CM; Pollock CA; Chen XM
Sci Rep; 2016 Jul; 6():29196. PubMed ID: 27381856
[TBL] [Abstract][Full Text] [Related]
27. Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2.
Watanabe R; Nakamura H; Masutani H; Yodoi J
Pharmacol Ther; 2010 Sep; 127(3):261-70. PubMed ID: 20435060
[TBL] [Abstract][Full Text] [Related]
28. Effect of tranilast in early-stage diabetic nephropathy.
Soma J; Sato K; Saito H; Tsuchiya Y
Nephrol Dial Transplant; 2006 Oct; 21(10):2795-9. PubMed ID: 16820373
[TBL] [Abstract][Full Text] [Related]
29. Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice.
Lassila M; Jandeleit-Dahm K; Seah KK; Smith CM; Calkin AC; Allen TJ; Cooper ME
J Am Soc Nephrol; 2005 Feb; 16(2):363-73. PubMed ID: 15625075
[TBL] [Abstract][Full Text] [Related]
30. Impaired cardiac anti-oxidant activity in diabetes: human and correlative experimental studies.
Connelly KA; Advani A; Advani SL; Zhang Y; Kim YM; Shen V; Thai K; Kelly DJ; Gilbert RE
Acta Diabetol; 2014 Oct; 51(5):771-82. PubMed ID: 24925443
[TBL] [Abstract][Full Text] [Related]
31. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic role of arjunolic acid in response to streptozotocin mediated diabetic renal injury: activation of polyol pathway and oxidative stress responsive signaling cascades.
Manna P; Sinha M; Sil PC
Chem Biol Interact; 2009 Oct; 181(3):297-308. PubMed ID: 19682444
[TBL] [Abstract][Full Text] [Related]
33. Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters.
Abo-Salem OM; El-Edel RH; Harisa GE; El-Halawany N; Ghonaim MM
Pak J Pharm Sci; 2009 Apr; 22(2):205-10. PubMed ID: 19339234
[TBL] [Abstract][Full Text] [Related]
34. Tranilast attenuates structural and functional aspects of renal injury in the remnant kidney model.
Kelly DJ; Zhang Y; Gow R; Gilbert RE
J Am Soc Nephrol; 2004 Oct; 15(10):2619-29. PubMed ID: 15466266
[TBL] [Abstract][Full Text] [Related]
35. Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-alpha stimulation, and effects of a phosphodiesterase inhibitor.
Koike N; Takamura T; Kaneko S
Life Sci; 2007 Apr; 80(18):1721-8. PubMed ID: 17346751
[TBL] [Abstract][Full Text] [Related]
36. Hexosamine induction of oxidative stress, hypertrophy and laminin expression in renal mesangial cells: effect of the anti-oxidant alpha-lipoic acid.
Singh LP; Cheng DW; Kowluru R; Levi E; Jiang Y
Cell Biochem Funct; 2007; 25(5):537-50. PubMed ID: 16892452
[TBL] [Abstract][Full Text] [Related]
37. Chronic COX inhibition reduces diabetes-induced hyperfiltration, proteinuria, and renal pathological markers in 36-week B6-Ins2(Akita) mice.
Nasrallah R; Robertson SJ; Hébert RL
Am J Nephrol; 2009; 30(4):346-53. PubMed ID: 19609076
[TBL] [Abstract][Full Text] [Related]
38. High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism.
Qi W; Chen X; Zhang Y; Holian J; Mreich E; Gilbert RE; Kelly DJ; Pollock CA
Nephrol Dial Transplant; 2007 Nov; 22(11):3147-53. PubMed ID: 17664181
[TBL] [Abstract][Full Text] [Related]
39. Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients.
Aslan M; Sabuncu T; Kocyigit A; Celik H; Selek S
Nutr Metab Cardiovasc Dis; 2007 Dec; 17(10):734-40. PubMed ID: 17321120
[TBL] [Abstract][Full Text] [Related]
40. Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy.
Li JJ; Lee SH; Kim DK; Jin R; Jung DS; Kwak SJ; Kim SH; Han SH; Lee JE; Moon SJ; Ryu DR; Yoo TH; Han DS; Kang SW
Am J Physiol Renal Physiol; 2009 Jul; 297(1):F200-9. PubMed ID: 19369290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
